Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

Strides recalls Losartan Potassium table

Strides recalled 2700 bottles of Losartan Potassium USP 25 mg tablets in US for presence

Qvents
July 7, 2023

FDA withdraws approval Oxandrin (Oxandro

Qvents
July 3, 2023

Eleven observations in USFDA 483 to IPCA

IPCA Ratlam (India) was issued USFDA 483 with 11 observations after inspection in June 2023

Qvents
July 3, 2023

Sun Pharma initiates a Class II recall o

Qvents
July 1, 2023

US FDA approves Pfizer’s hair loss

Qvents
June 26, 2023

Lupin wins first approval for generic Ti

Qvents
June 23, 2023

FDA on Friday approved Lexicon’s heart

</a> Marketing Authorisation on the request of MA holder Guidehouse Germany GmbH)

Qvents
May 31, 2023

FDA has published the USFDA 483 issued t

Qvents
May 31, 2023

Aurobindo Pharma USA recalls 87,360 bott

Qvents
May 30, 2023

Sun Pharma Recall Antidepressant Drug fo

In May 2023, Sun Pharma initiated recall of two lots of antidepressant drug Bupropion Hydrochloride

Qvents
May 29, 2023